BMC Cancer

Table 4 Backgrounds of ChE-stable and -worse cases receiving the combination therapy

From: Transhepatic arterial infusion chemotherapy using a combination of miriplatin and CDDP powder versus miriplatin alone in the treatment of hepatocellular carcinoma: a randomized controlled trial

ChE	Case	Dead/Alive	Period	TNM	Child-Pugh
Stable^a	1	Dead	334	III	A
	2	Dead	444	III	B
	3	Dead	541	II	B
	4	Alive	695	III	A
	5	Alive	1576	III	A
	6	Alive	1695	II	A
Worse^a	7	Dead	382	II	A
	8	Dead	700	II	A
	9	Dead	765	III	A
	10	Alive	779	II	B

^a The serum concentration of cholinesterase (ChE) got less than 80% of the initial concentration (Worse) or stayed at 80% or higher (Stable)

Back to article page

ISSN: 1471-2407

Contact us

Submission enquiries: bmccancer@biomedcentral.com
General enquiries: ORSupport@springernature.com